设计2 - 氨基佐衍生物以多学科碎片杂交方法向trypanosomatid PTR1的设计
Joanna Panecka-Hofman1,2, Pasquale Linciano3,4, Ina Pöhner1,5
1Molecular and Cellular Modeling Group, Heidelberg Institute for Theoretical Studies (HITS), D-69118 Heidelberg, Germany.
Journal of medicinal chemistry
|September 30, 2025
概括
研究人员开发了新的化合物,其向的是试索马类药物中的瑞丁降解酶1 (PTR1). 这些抑制剂对睡眠病和莱什曼病有很大的承诺,与以前的候选药物相比,它们提供了更好的疗效和更低的毒性.
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 瑞丁减少酶1 (PTR1) 是一种关键的酶在叶酸代谢的病原性trypanosomatids.
- PTR1是被忽视的热带疾病的有效药物标,如睡眠病和莱什曼病.
- 之前的抑制剂针对PTR1酶内的不同口袋.
研究的目的:
- 通过结合已知的药理,设计和合成新的PTR1抑制剂.
- 评估这些新化合物对Trypanosoma brucei PTR1 (TbPTR1) 和Leishmania major PTR1 (LmPTR1) 的in silico和in vitro疗效.
- 研究结构-活性关系 (SAR),以优化抑制剂的效力和降低毒性.
主要方法:
- 化合物库的in silico选对TbPTR1和LmPTR1.1进行检测.
- 新型化合物的化学合成,其中包括由各种结构连接的2-aminobenzothiazole和二甲部分.
- 在体外酶抑制试验和抗寄生虫活性测试.
- 结构-活性关系分析,得到量子化学计算和X射线晶体学的支持.
主要成果:
- 两种合成的化合物,1a和1b,证明了TbPTR1.1.的强烈抑制.
- 化合物1b对LmPTR1表现出活性,对婴儿莱什马尼亚有中等的疗效.
- 结构-活性关系研究表明,元化比副化更有利.
- 碎片混合化策略产生了比参考化合物I有更低毒性和更高有效性的化合物.
结论:
- 碎片杂交的方法是有效的开发强效和更少的毒性PTR1抑制剂.
- 新合成的化合物代表了治疗松胺感染的有希望的线索.
- 基于SAR和结构洞察力的进一步优化可能会导致先进的抗寄生虫药物候选者.
相关概念视频
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...